Synthesis of cyclo-L-prolyl-glycine and study of its anti-parkinsonian activity
The aim of the work was to develop an optimal scheme for the synthesis of substance of cyclo-L-prolylglycine neuropeptide (CPG), a potential drug useful for the integrated treatment of psychiatric pathologies, including anxiety, depressive disorders and cognitive impairment. Two 4-stage CPG synthesi...
Saved in:
Main Authors: | Ksenia Koliasnikova, Anna Golubyatnikova, Alexey Rebeko, Marina Vukolova, Polina Povarnina, Elena Kuznetsova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC “Publisher OKI”
2019-09-01
|
Series: | Фармакокинетика и Фармакодинамика |
Subjects: | |
Online Access: | https://www.pharmacokinetica.ru/jour/article/view/98 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative pharmacokinetics and pharmacodinamics of noopept, its activity metabolite cycloprolylglycine and piracetam
by: Svetlana Boyko, et al.
Published: (2019-09-01) -
The influence of the pharmacokinetics and bioavailability of cyclo-L-propylglycine to the manifestation of its main pharmacological effects in experimental animals
by: S. S. Boyko, et al.
Published: (2021-06-01) -
Comparative study of pharmacokinetics and enzymatic resistance of the neuroprotective mean GZK-111 and noopept in rats
by: S. S. Boyko, et al.
Published: (2022-12-01) -
Pharmacokinetics and neurotropic effects of cyclo-L-prolylglycine and its modified analogues
by: S. S. Boyko, et al.
Published: (2022-01-01) -
Effect of cyclo-L-prolylglycine on pain response thresholds and morphine-induced analgesia in inbred BALB/c and C57Bl/6 mice
by: A. V. Nadorova, et al.
Published: (2024-11-01)